9 results
IP Health Blog
FDA Draft Guidance on Postapproval Changes to Drug Substances FDA Draft Guidance on Postapproval Changes to Drug Substances
September 25, 2018
IP Health Blog
Sixth Circuit Affirms That in Context, Attractive Ingredient Photos Are Mere Puffery in Wysong v. APN Sixth Circuit Affirms That in Context, Attractive Ingredient Photos Are Mere Puffery in Wysong v. APN
June 22, 2018
IP Health Blog
FDA Draft Guidance on Proprietary Names for New Animal Drugs FDA Draft Guidance on Proprietary Names for New Animal Drugs
March 13, 2018
IP Health Blog
FDA Solicits Public Comments and Information for Review of Veterinary Regulations FDA Solicits Public Comments and Information for Review of Veterinary Regulations
September 11, 2017
IP Health Blog
A New Approach to Quantify the Toxicity of Short-Term Exposure to Veterinary Drug Residues A New Approach to Quantify the Toxicity of Short-Term Exposure to Veterinary Drug Residues
August 28, 2017
IP Health Blog
All Electronic Submissions to the Center for Veterinary Medicine Must Use New CVM eSubmitter by March 2018 All Electronic Submissions to the Center for Veterinary Medicine Must Use New CVM eSubmitter by March 2018
August 21, 2017
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.